Contemporary scientific research reflects a growing focus on complexity and collaboration. Novel therapeutic modalities - mRNA therapeutics, antibody–drug conjugates, and cell and gene therapies - now ...

Regulators found the company had relied heavily on AI systems to generate key documents, including drug specifications, procedures and production records, without sufficient human oversight.

The UK government has launched a landmark £500 million national effort, Sovereign AI, designed to transform Britain into a global leader in artificial intelligence by backing its most promising ...

This addition further expands Qlucore's portfolio of advanced testing solutions, which already includes Qlucore Insights Leukaemia (AML), Qlucore Insights Lung Cancer and Qlucore Diagnostics Pediatric ...

As the drug discovery community navigates the transition from manual, paper-based workflows to digitally enhanced environments, contract research organizations (CROs) like Novalix are leading the ...

Having digitized (from paper to glass) through the late 1990s and early 2010s, the R&D community is now navigating the early adoption of digitalization and digitally enhanced workflows. Now available ...

NIST researchers Grant Brodnik, Alexa Carollo, Lindell Williams and Scott Papp, among others, worked to make integrated circuits for light by depositing complex patterns of specialised materials onto ...

The platform offers access to more than 40 AI biology models, supported by AI-guided selection tools that help researchers choose the most suitable models for their specific goals.

State of the Global Quantum Industry report reveals the "growth of European leadership and the speed that the industry is ...

The UK government has launched a landmark £500 million national effort, Sovereign AI, designed to transform Britain into a global leader in artificial intelligence by backing its most promising ...